Abstract
Current Medicinal Chemistry - Anti-Cancer Agents
Title: Subject Index To Volume 2
Volume: 3Issue: 1
Author(s): Bentham Science Publishers
Affiliation:
Abstract:
Export Options
About this article
Cite this article as:
Bentham Science Publishers , Subject Index To Volume 2, Current Medicinal Chemistry - Anti-Cancer Agents 2003; 3 (1) .https://dx.doi.org/10.2174/1568011033353588
| DOI https://dx.doi.org/10.2174/1568011033353588 | Print ISSN 1568-0118 |
| Publisher Name Bentham Science Publisher | Online ISSN 1875-5968 |
Related Journals
Related Books
Nanomaterials in Glioblastoma Research, Diagnosis and Therapy
Advancements in Cancer Research: Exploring Diagnostics and Therapeutic Breakthroughs
Frontiers in Clinical Drug Research - Anti-Cancer Agents
The Management of Metastatic Triple-Negative Breast Cancer: An Integrated and Expeditionary Approach
Cancer Genes
Cancer Medicine in an Ayurvedic Perspective: A Critical Overview
Cancer Genes
Anticancer Immunity: Reviewing the Potential of Probiotics
Probiotics in Anticancer Immunity
Phytonutrients in the Treatment of Gastrointestinal Cancer
8Related Articles
- Drug Repurposing in Chemical Genomics: Can We Learn from the Past to Improve the Future?
Current Topics in Medicinal ChemistryImmunomodulatory Activity of Astragalus, Ginseng and Echinacea: From Keith Block and Mark Mead to Today, Have We Moved On?
Current Immunology Reviews (Discontinued) Synthesis and Cytotoxic Evaluation of Novel Symmetrical Taspine Derivatives as Anticancer Agents
Medicinal ChemistryReceptor Tyrosine Kinases Take a Direct Route to Mitochondria: An Overview
Current Protein & Peptide ScienceNovel Therapeutic Strategies for Dementia
CNS & Neurological Disorders - Drug TargetsConstruction of an Oxidative Stress Risk Model to Analyze the Correlation Between Liver Cancer and Tumor Immunity
Current Cancer Drug Targets Recent Advances in Cancer Therapy: An Overview
Current Pharmaceutical DesignMicroRNAs in Breast Cancer Therapy
Current Pharmaceutical Design Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics
Current Medicinal ChemistryH3K4 Methylation Status and Lysine Specific Methyltransferase KMT2C Expression Correlate with Prognosis in Lung Adenocarcinoma
Current Molecular PharmacologyThe Influence of Surface Charge on the Antiviral Effect of Curcumin Loaded in Nanocarrier System
Pharmaceutical NanotechnologyJumping on the Train of Personalized Medicine: A Primer for Non- Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area
Current Psychiatry ReviewsA Computational Study of Three Frequent Mutations of EGFR and their Effects on Protein Dimer Formation and Non-Small Cell Lung Cancer Drug Resistance
Current BioinformaticsBeneficial Outcomes of Cancer Therapeutic Modalities Based on TargetingApoptosis
Current Drug TargetsBiosystems Engineering of Prokaryotes with Tumor-Killing Capacities
Current Pharmaceutical DesignIn Silico Modeling for the Design of 2-substitted Benzimidazole Derivatives, and Prediction of Activity as Procaspase-3 Activators and Apoptosis Inducer
Letters in Drug Design & DiscoveryAn Exploration of Organoid Technology: Present Advancements,Applications, and Obstacles
Current Pharmaceutical BiotechnologyFlavonoids as Prospective Aromatase Inhibitors in Breast Cancer Prevention/ Therapy
Current Molecular PharmacologyCancer Immunomics in the Age of Information: Role in Diagnostics and Beyond
Current Pharmaceutical DesignMechanisms of Resistance to Chemotherapy in Gastric Cancer
Anti-Cancer Agents in Medicinal Chemistry
[8]ページ先頭